|
DNAH14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.025400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.656000E-01 |
| Normal-vs-Stage2 |
5.277600E-01 |
| Normal-vs-Stage3 |
4.102400E-01 |
| Normal-vs-Stage4 |
6.086500E-02 |
| Stage1-vs-Stage2 |
1.559980E-01 |
| Stage1-vs-Stage3 |
9.026400E-01 |
| Stage1-vs-Stage4 |
8.282300E-02 |
| Stage2-vs-Stage3 |
1.379230E-01 |
| Stage2-vs-Stage4 |
2.371700E-02 |
| Stage3-vs-Stage4 |
1.617360E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.814000E-01 |
| Normal-vs-AfricanAmerican |
4.169200E-01 |
| Normal-vs-Asian |
7.205400E-01 |
| Caucasian-vs-AfricanAmerican |
9.132000E-01 |
| Caucasian-vs-Asian |
5.356600E-01 |
| AfricanAmerican-vs-Asian |
6.040800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.554200E-01 |
| Normal-vs-Female |
2.584800E-01 |
| Male-vs-Female |
1.489790E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.805000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.874600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.679150E-01 |
| Normal-vs-Age(81-100Yrs) |
8.909200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.880600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.317800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.887800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.052400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.501800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.028000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.587000E-01 |
| Classical-VS-Follicular |
4.41300000000311E-05 |
| Classical-VS-Other |
7.081000E-01 |
| Classical-VS-Normal |
1.032150E-01 |
| Tall-VS-Follicular |
3.299800E-03 |
| Tall-VS-Other |
5.332800E-01 |
| Tall-VS-Normal |
1.229990E-01 |
| Follicular-VS-Other |
2.853800E-01 |
| Follicular-VS-Normal |
1.179600E-01 |
| Other-VS-Normal |
7.388200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.282800E-01 |
| Normal-vs-N1 |
1.815740E-02 |
| N0-vs-N1 |
5.632900E-04 |
|
|
